UK Government announces prescription price hike to record level

February 28, 2018  Source: pharmafile 531

The UK Government has announced plans to increase prescription charges by 20p, or 2.3%, to a record £8.80, effective 1 April.

The plans were announced by Conservative Health Minister Lord O’Shaughnessy, who said: “We have increased the prescription charge by 20p from £8.60 to £8.80 for each medicine or appliance dispensed.”

Prescription prepayment certificates, available in annual and three-month forms at £29.10 and £104 respectively, will be unaffected by the rise to “ensure that those with the greatest need, and who are not already exempt from the charge, are protected.” According to the government, prescription charge income is expected to rise “broadly in line” with inflation.

The move is designed to help the government deliver its commitment to cut £22 billion from the NHS in “efficiency savings” and inject £10 billion into its front-line services, as outlined in its Five Year Forward View as part of the 2015 Spending Review.

However, the move has unsurprisingly been met with criticism. Matina Loizou, co-Chair of the Prescription Charges Coalition and Health Policy and Campaigns Lead at Parkinson's UK remarked: “This hike will be catastrophic for people with long-term, or life-long, conditions: 20p per prescription can put further strain on already stretched budgets. Many people are unable to work full-time because of their condition and on top of additional costs – such as specialist transport or specific dietary requirements – prescriptions charges can push them over the limit.

She continued: “We’ve heard distressing and alarming experiences from people who are facing impossible choices over whether they should eat, heat their home or pay for essential medications. The Government needs to ease, not increase, the financial burden on those who have already endured enough.”

By Ddu
Share: 

your submission has already been received.

OK

Subscribe

Please enter a valid Email address!

Submit

The most relevant industry news & insight will be sent to you every two weeks.